MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation.

MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation.
复制标题

DOI:
10.1007/s11095-012-0936-9
复制
发表时间:
2013-04
影响因子:
3.7
通讯作者:
Shim, Hyunsuk
Shim, Hyunsuk
中科院分区:
医学3区
文献类型:
--
作者:
Liang, Zhongxing;Ahn, Jeffrey;Guo, Donna;Votaw, John R.;Shim, Hyunsuk

文献摘要

参考文献

被引文献

相似文献

实体瘤可能对放射治疗产生耐药性或产生耐药性。本研究的目的是探讨microRNA-302是否参与了放射耐药,是否可以作为增敏剂来提高乳腺癌细胞对放射治疗的敏感性。分析MiR-302在耐辐射细胞系中的表达水平,并与亲本细胞系进行比较。此外,我们在体外和体内研究了miR-302的强制表达是否使放射耐药乳腺癌细胞对电离辐射敏感。MiR-302在辐照的乳腺癌细胞中下调。此外,miR-302a的表达水平与AKT1和RAD52的表达水平呈负相关,而AKT1和RAD52是辐射抗性的两个关键调节因子。更有希望的是,miR-302a在体外和体内使放射耐药乳腺癌细胞对放射治疗增敏,并降低AKT1和RAD52的表达。我们的研究结果表明,miR-302表达的降低赋予了放射抗性,miR-302基线表达的恢复使乳腺癌细胞对放疗敏感。这些数据表明miR-302是一种潜在的放疗增敏剂。
Solid tumors can be resistant or develop resistance to radiotherapy. The purpose of this study is to explore whether microRNA-302 is involved in radioresistance and can be exploited as a sensitizer to enhance sensitivity of breast cancer cells to radiation therapy. MiR-302 expression levels in radioresistant cell lines were analyzed in comparison with their parent cell lines. Furthermore, we investigated whether enforced expression of miR-302 sensitized radioresistant breast cancer cells to ionizing radiation in vitro and in vivo. MiR-302 was downregulated in irradiated breast cancer cells. Additionally, the expression levels of miR-302a were inversely correlated with those of AKT1 and RAD52, two critical regulators of radioresistance. More promisingly, miR-302a sensitized radioresistant breast cancer cells to radiation therapy in vitro and in vivo and reduced the expression of AKT1 and RAD52. Our findings demonstrated that decreased expression of miR-302 confers radioresistance and restoration of miR-302 baseline expression sensitizes breast cancer cells to radiotherapy. These data suggest that miR-302 is a potential sensitizer to radiotherapy.
DOI: 10.1038/nature03702
发表时间: 2005-06-09
期刊: NATURE
影响因子: 64.8
作者:
Lu, J;Getz, G;Golub, TR
通讯作者: Golub, TR
DOI: 10.1002/pros.20827
发表时间: 2008-11-01
期刊: PROSTATE
影响因子: 2.8
作者:
Josson, Sajni;Sung, Shian-Ying;Lao, Kaiqin;Chung, Leland W. K.;Johnstone, Peter A. S.
通讯作者: Johnstone, Peter A. S.
DOI: 10.1093/nar/gkj112
发表时间: 2006-01-01
影响因子: 14.9
作者:
Griffiths-Jones S;Grocock RJ;van Dongen S;Bateman A;Enright AJ
通讯作者: Enright AJ
DOI: 10.1038/34937
发表时间: 1998-01-22
期刊: NATURE
影响因子: 64.8
作者:
Benson, FE;Baumann, P;West, SC
通讯作者: West, SC
DOI: 10.1158/0008-5472.can-03-3958
发表时间: 2004-06-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Liang, ZX;Wu, T;Shim, H
通讯作者: Shim, H